Combination therapy with peptide epoxyketones
US10596222B2 · kind B2 · utility
0Cited by
76References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2016 |
| Grant date | Mar 24, 2020 |
| Priority date | — |
| Expiry date | Nov 2, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides combination therapy, wherein one or more other therapeutic agents are administered agents are administered with peptide epoxyketones or a pharmaceutically acceptable salt thereof. Another aspect of the invention relates to treating cancer with a peptide epoxyketone administered in combination with another therapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.